猪β防御素-2对猪链球菌感染小鼠的治疗效果评价

doi:10.11843/j.issn.0366-6964.2020.12.025

Abstract

Abstract: Defensin is a small cationic peptide widely distributed in animals and plants. It is an important component of the innate immune defense system of mammals. It has a broad spectrum of antibacterial, antiviral and antifungal activities. Porcine β-defensin-2 (PBD-2) is one of the natural defensins expressed in pigs and has good antibacterial activity in vitro. The purpose of this study is to evaluate the therapeutic effect of PBD-2 in the treatment of Streptococcus suis infection in animals and to provide more insights for evaluating the value of PBD-2 as a therapeutic drug. Firstly, the bactericidal activity of PBD-2 against S. suis clinical isolate SC-19 was measured in vitro, and the cytotoxicity of PBD-2 was tested on mouse-derived macrophages (RAW264.7). Subsequently, C57 female mice aged 4-6 weeks and weighing between 18-22 g infected with S. suis SC-19 were treated with PBD-2 or PBS (n ≥ 6). The survival rate of mice, and the bacteria loads, inflammatory cytokine levels, and pathological changes of tissues were determined. The results showed that PBD-2 (25-200 μg·mL^-1) could significantly inhibit the growth of S. suis SC-19 in a concentration-dependent manner (P<0.05). At the same time, PBD-2 had no significant toxic effect on RAW cells (P>0.05). The in vivo study revealed that PBD-2 treatment could effectively reduce the mortality of mice infected with S. suis SC-19. At the same time, PBD-2 treatment significantly reduced bacteria loads in brain, lung, spleen and blood of mice, and decreased the levels of inflammatory cytokines IL-6, IL-12 and TNF-α in mouse sera (P<0.05). At the same time, PBD-2 treatment also significantly alleviated the degree of pathological damages in lung and spleen tissues of mice infected with bacteria (P<0.05). These results indicate that PBD-2 confers great resilience to S. suis in vitro without significant cytotoxicity, while it also exhibits a therapeutic effect on S. suis infection in mice, suggesting that the use of PBD-2 as a therapeutic drug and substitutes for antibiotics is of an excellent prospect.

Key words: porcine β-defensin-2, bacterial infection, treatment, Streptococcus suis

CLC Number:

S855.11

WANG Antian, HUANG Jing, SONG Bingxiao, SUN Yufan, ZHOU Rui, LI Lu. Evaluation of Therapeutic Effect of Porcine β-defensin-2 on Streptococcus suis Infection[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(12): 3160-3170.

References 33

[1]	ALLEN H K, LEVINE U Y, LOOFT T et al. Treatment, promotion, commotion:antibiotic alternatives in food-producing animals[J]. Trends Microbiol, 2013, 21(3):114-119.
[2]	KHURSHID Z, ZAFAR M S, NASEEM M, et al. Human oral defensins antimicrobial peptides:a future promising antimicrobial drug[J]. Curr Pharm Des, 2018, 24(10):1130-1137.
[3]	VELDHUIZEN E J A, VAN DIJK A, TERSTEEG M H G, et al. Expression of β-defensins pBD-1 and pBD-2 along the small intestinal tract of the pig:lack of upregulation in vivo upon Salmonella typhimurium infection[J]. Mol Immunol, 2007, 44(4):276-283.
[4]	YANG X, CHENG Y T, TAN M F, et al. Overexpression of porcine beta-defensin 2 enhances resistance to Actinobacillus pleuropneumoniae infection in pigs[J]. Infect Immun, 2015, 83(7):2836-2843.
[5]	HUANG J, QI Y H, WANG A T, et al. Porcine β-defensin 2 inhibits proliferation of pseudorabies virus in vitro and in transgenic mice[J]. Virol J, 2020, 17(1):18.
[6]	VELDHUIZEN E J A, RIJNDERS M, CLAASSEN E A, et al. Porcine β-defensin 2 displays broad antimicrobial activity against pathogenic intestinal bacteria[J]. Mol Immunol, 2008, 45(2):386-394.
[7]	PENG Z X, WANG A R, XIE L Q, et al. Use of recombinant porcine β-defensin 2 as a medicated feed additive for weaned piglets[J]. Sci Rep, 2016, 6(1):26790.
[8]	PENG Z X, WANG A R, FENG Q Y, et al. High-level expression, purification and characterisation of porcine β-defensin 2 in Pichia pastoris and its potential as a cost-efficient growth promoter in porcine feed[J]. Appl Microbiol Biotechnol, 2014, 98(12):5487-5497.
[9]	TANG Z R, XU L, SHI S B, et al. Oral administration of synthetic porcine beta-defensin-2 improves growth performance and cecal microbial flora and down-regulates the expression of intestinal toll-like receptor-4 and inflammatory cytokines in weaned piglets challenged with enterotoxigenic Escherichia coli[J]. Anim Sci J, 2016, 87(10):1258-1266.
[10]	王海燕. 猪链球菌病及其疫苗研究进展[J]. 中国畜牧兽医文摘, 2018, 34(6):249.WANG H Y. Research progress of Streptococcus suis and its vaccine[J]. Chinese Abstracts of Animal Husbandry and Veterinary Medicine, 2018, 34(6):249. (in Chinese)
[11]	LUN Z R, WANG Q P, CHEN X G, et al. Streptococcus suis:an emerging zoonotic pathogen[J]. Lancet Infect Dis, 2007, 7(3):201-209.
[12]	王振超. 猪链球菌的临床症状及防治措施[J]. 中国动物保健, 2020, 22(2):5, 14.WANG Z C. Clinical symptoms and preventive measures of Streptococcus suis[J]. China Animal Health, 2020, 22(2):5, 14. (in Chinese)
[13]	HUANG C, YANG X, HUANG J, et al. Porcine beta-defensin 2 provides protection against bacterial infection by a direct bactericidal activity and alleviates inflammation via interference with the tlr4/nf-κb pathway[J]. Front Immunol, 2019, 10:1673.
[14]	农业农村部.中华人民共和国农业农村部公告第194号[EB/OL].(2019-07-10)[2020-07-01].http://www.xmsyj.moa.gov.cn/zcjd/201907/t20190710_6320678.htm. Ministry of Agriculture and Rural Affairs. Announcement No.194 of the Ministry of Agriculture and Rural affairs of the People's Republic of China[EB/OL].(2019-07-10)[2020-07-01].http://www.xmsyj.moa.gov.cn/zcjd/201907/t20190710_6320678.htm. (in Chinese)
[15]	JENSEN H M. Health management with reduced antibiotic use-experiences of a Danish pig vet[J]. Anim Biotechnol, 2006, 17(2):189-194.
[16]	KANG H K, KIM C, SEO C H, et al. The therapeutic applications of antimicrobial peptides (AMPs):a patent review[J]. J Microbiol, 2017, 55(1):1-12.
[17]	RIVAS-SANTIAGO B, CASTAÑEDA-DELGADO J E, RIVAS SANTIAGO C E, et al. Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models[J]. PLoS One, 2013, 8(3):e59119.
[18]	JIAO J, MAO R Y, TENG D, et al. In vitro and in vivo antibacterial effect of NZ2114 against Streptococcus suis type 2 infection in mice peritonitis models[J]. AMB Express, 2017, 7(1):44.
[19]	DENG Z, WANG J, LYU W T, et al. Development of a cell-based high-throughput screening assay to identify porcine host defense peptide-inducing compounds[J]. J Immunol Res, 2018, 2018:5492941.
[20]	HUANG J, QI Y H, WANG A T, et al. Porcine β-defensin 2 inhibits proliferation of pseudorabies virus in vitro and in transgenic mice[J]. Virol J, 2020, 17:18.
[21]	HAAS B, GRENIER D. Understanding the virulence of Streptococcus suis:a veterinary, medical, and economic challenge[J]. Med Mal Infect, 2018, 48(3):159-166.
[22]	BROGDEN K A. Antimicrobial peptides:pore formers or metabolic inhibitors in bacteria?[J]. Nat Rev Microbiol, 2005, 3(3):238-250.
[23]	TOKE O. Antimicrobial peptides:new candidates in the fight against bacterial infections[J]. Biopolymers, 2005, 80(6):717-735.
[24]	CHEN R B, ZHANG K, ZHANG H, et al. Analysis of the antimicrobial mechanism of porcine beta defensin 2 against E. coli by electron microscopy and differentially expressed genes[J]. Sci Rep, 2018, 8(1):14711.
[25]	MAEDA T, SAKIYAMA T, KANMURA S, et al. Low concentrations of human neutrophil peptide ameliorate experimental murine colitis[J]. Int J Mol Med, 2016, 38(6):1777-1785.
[26]	VRIENS K, COOLS T L, HARVEY P J, et al. The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms[J]. Peptides, 2016, 75:71-79.
[27]	CHEN H L, SU P Y, SHI H C. Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement[J]. Appl Microbiol Biotechnol, 2016, 100(21):9125-9132.
[28]	LIN L, XU L, LV W H, et al. An NLRP3 inflammasome-triggered cytokine storm contributes to Streptococcal toxic shock-like syndrome (STSLS)[J]. PLoS Pathog, 2019, 15(6):e1007795.
[29]	HAN F F, Zhang H W, XIA X, et al. Porcine β-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis[J]. J Immunol, 2015, 194(4):1882-1893.
[30]	COSTA F, TEIXEIRA C, GOMES P, et al. Clinical application of AMPs[M]//MATSUZAKI K. Antimicrobial Peptides:Basics for Clinical Application. Singapore:Springer, 2019:281-298.
[31]	李丘轲,李金泽, 吴华,等.靶向抗菌肽的设计策略与应用[J].畜牧兽医学报,2020,51(2):243-251.LI Q K, LI J Z, WU H,et al. Design strategy and application on targeted antimicrobial peptides[J]. Acta Veterinaria et Zootechnica Sinica, 2020,51(2):243-251. (in Chinese)
[32]	李连彬. 菌丝霉素源抗菌肽对金黄色葡萄球菌乳腺炎的防治及其耐药产生机制的研究[D]. 杨凌:西北农林科技大学, 2018.LI L B. Effect of plectasin-derived antimicrobial peptides on S. Aureus mastitis and the study on mechanism of antimicrobial peptides resistance development[D]. Yangling:Northwest A&F University, 2018. (in Chinese)
[33]	WANG S, ZENG X F, YANG Q, et al. Antimicrobial peptides as potential alternatives to antibiotics in food animal industry[J]. Int J Mol Sci, 2016, 17(5):603.

Evaluation of Therapeutic Effect of Porcine β-defensin-2 on Streptococcus suis Infection

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 33

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	LI Pengxu, LI Shijing, SUN Jun, XIANG Wei, ZHAO Miaomiao, HOU Tianmu, LI Huaming, GUANG Min, CHEN Ruige, XU Mengran, WU Xiaomin, JIANG Hexiang, LEI Liancheng, ZHANG Fuxian. Molecular Subtyping and Identification of Streptococcus suis Meningitidis Type 2 and Its Biological Characteristics [J]. Acta Veterinaria et Zootechnica Sinica, 2024, 55(3): 1192-1207.
[2]	MA Tianwen, WANG Yingxue, WANG Minghe, CHI Xinyu, WANG Shu, GAO Li, WEI Chengwei. Clinical Diagnosis, Treatment and Prognosis of Intestinal Lymphadenopathy in Canine [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(7): 3102-3107.
[3]	MAO Peng, WANG Zhihao, LI Jianji, CUI Luying, ZHU Guoqiang, MENG Xia, DONG Junsheng, WANG Heng. Research Progress of Ferroptosis in Bacterial Infection [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(6): 2280-2287.
[4]	SUN Yufan, YU Panyuan, CHEN Hongyu, TAN Yiqing, CHEN Xiabing, ZHANG Tengfei, GAO Ting, ZHOU Rui, LI Lu. Evaluation of the Efficacy of Potassium Diformate in the Prevention of Salmonella Infection and the Effect on Intestinal Flora [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(5): 2101-2113.
[5]	YAN Lang, LI Xinqiu, GAO Pingping, JIANG Wanlu, ZHANG Di. Retrospective Analysis of Clinical Features and Treatment Response of Feline Pruritic Skin Diseases [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(3): 1325-1332.
[6]	YANG Yanbei, XU Jing, LIU Wanping, TAO Aini, FENG Yulin, SUN Yong, WANG Chuang, LIU Jian. Effects of Low-concentration Azitromycin on Protein Expression, Capsular Polysaccharides and Drug Susceptibility of Streptococcus suis Type 2 [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(2): 757-765.
[7]	Lü Ruoyi, SI Xiaohui, SUN Zhigang, SHI Xiaomin, LIU Xiaoye. Drug Resistance Situation of Streptococcus suis and Prevention Measures of Infections [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(12): 4920-4933.
[8]	LEI Yaping, ZHOU Shiwei, TENG Yumeng, NONG Bidan, PANG Xiaomin, ZHANG Yi, LIU Xiaoli, WANG Yulian, HU Xueying. Effect Evaluation of Maxing Shigan Oral Liquid in the Treatment of Broiler Chicken Infected with Mycoplasma gallisepticum [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(12): 5264-5274.
[9]	WANG Chenyan, ZHOU Feng, SHAO Guoqing, HOU Bo. Analysis of the Effect of Macleaya Cordata Extract in Conjunction with Antibiotics Treatment on the Natural Infection of Mycoplasma Synovia in Commercial Breeding Hens [J]. Acta Veterinaria et Zootechnica Sinica, 2023, 54(11): 4827-4838.
[10]	YAN Rui, REN Yi, CHEN Qiuhui, LI Zhengzhi, YANG Jinghan, ZHAO Tianrui, LEI Yifei, HU Changmin. Feline Lower Urinary Tract Syndrome [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(8): 2470-2478.
[11]	ZHU Huquan, YE Peiyu, SONG Zhaomeng, WANG Kai, CAO Changyu. Comparison of the Effect of a Case of Cat Idiopathic Chylothorax Thoracoscopic Surgery and Conservative Therapy [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(4): 1317-1320.
[12]	ZHANG Shanshan, HE Bin, LI Shuguang, LIU Mingcheng, JIANG Jinqing, HU Jianhe, LEI Liancheng, SHEN Zhiqiang, XIA Xiaojing. Rapid Detection of Streptococcus suis with Visual RPA-LFD Technology [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(2): 538-547.
[13]	HAN Xuejiao, LI Liang, ZHAN Songhe, DUAN Qianqian, CUI Lirong, LIU Xuelan, SUN Pei, WEI Jianzhong, LI Yu. Effects of Prophage on Virulence, Environmental Adaptability, Drug Resistance and Metabolic Activity of Streptococcus suis [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(1): 290-303.
[14]	LI Yaqi, WANG Xianzhong, ZHANG Jiaojiao. Research Progress of Cell Proliferation and Apoptosis Regulated by Non-thermal Plasma and Its Application in Animal Husbandry [J]. Acta Veterinaria et Zootechnica Sinica, 2022, 53(1): 1-10.
[15]	CHEN Nianci, WANG Siying, CHAI Xinyan, ZHAO Yong, YANG Wanlian, SUN Yanzheng, Lü Yanli. Observation on the Clinical Application Effect of Canine Parvovirus Specific Immunoglobulin [J]. Acta Veterinaria et Zootechnica Sinica, 2021, 52(9): 2682-2686.